Dr Peter Steer announced as new Mater Group Chief Executive Officer Chairman of the Board at Mater Group, Mr Brian Flannery announced this week that Dr Peter Steer has accepted an appointment to...

31

Jul

Dr Peter Steer announced as new Mater Group Chief Executive Officer

Mater researcher Professor Geoff Faulkner and his lab have published a paper that explores the development of resistance to chemotherapy in ovarian cancer. Each year 1400 Australian women are...

13

Jul

Mater Ovarian Cancer Research Collaborative

Prof Peter Nestor was recently appointed Conjoint Professor of Neuroscience between The University of Queensland and Mater and has started his appointment by establishing a memory clinic at Mater.

11

Jul

Memory clinic established at Mater

Two female researchers in Queensland have been awarded strategic grants as a step forward in closing the research and academic gender gap.

08

Mar

180K to support women changing our world

The world’s leading minds on ocular melanoma say more must be done to help the 50 per cent of patients who die from melanoma of the eye in Australia.

07

Mar

Australian killer receives international focus

A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.

31

Jan

Medicinal cannabinoids trial for symptom relief

Mater Research is proud to announce that Professor Brian Gabrielli and Professor Jean-Pierre Levesque have been awarded research grants through Cancer Council Queensland (CCQ).

15

Jan

Mater awarded grants for cancer research

Displaying results 229-235 (of 235)
 |<  <  11 - 12 - 13 - 14 - 15 - 16 - 17 - 18 - 19 - 20 >  >|